Katrina Mott

Katrina Mott is a Principal Scientist in Translational Epidemiology and Advanced Methods at Merck, focusing on the safety and effectiveness of vaccines administered to pregnant women in the United States. They have extensive experience in pharmacoepidemiology, including studies utilizing insurance claims databases, observational study design, and vaccine science. Previously, Katrina served as an Associate Principal Scientist at Merck, completed their Doctor of Science in Epidemiology at Harvard T.H. Chan School of Public Health, and held various roles including ORISE Fellow at FDA/CDER and Graduate Research Assistant at Johns Hopkins Bloomberg School of Public Health. Their research and collaborative efforts aim to inform regulatory, policy, and clinical decisions.